Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women

References

• Cohen I, Veille JC, Calkins BM. Improved pregnancy outcome following successful treatment of chlamydial infection. J Am Med Assoc. 1990;263(23):3160–3.10.1001/jama.1990.03440230056032
   Web of Science ®Google Scholar
• Rastogi S, Das B, Salhan S, Mittal A. Effect of treatment for Chlamydia trachomatis during pregnancy. Int J Gynaecol Obstet. 2003;80(2):129–137.10.1016/S0020-7292(02)00371-5
   PubMed Web of Science ®Google Scholar
• Andrews WW, Goldenberg RL, Mercer B, Iams J, Meis P, Moawad A, et al. The preterm prediction study: association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol. 2000;183(3):662–668.10.1067/mob.2000.106556
   PubMed Web of Science ®Google Scholar
• Odendaal HJ, Schoeman J. The association between Chlamydia trachomatis genital infection and spontaneous preterm labour. S Afr J Obstet Gynaecol. 2006;12(3):146–149.
   Google Scholar
• Blas MM, Canchihuaman FA, Alva IE, Hawes SE. Pregnancy outcomes in women infected with Chlamydia trachomatis: a population-based cohort study in Washington State. Sex Transm Infect. 2007;83(4):314–318.10.1136/sti.2006.022665
   PubMed Web of Science ®Google Scholar
• Postma MJ, Bakker A, Welte R, van Bergen JE, Van den Hoek JA, de Jong-van den Berg LT, et al. Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more. Ned Tijdschr Geneeskd. 2000;144(49):2350–2354.
   PubMedGoogle Scholar
• Rours GIJG, Verkooyen RP, Willemse HF, van der Zwaan EA, van Belkum A, de Groot R, et al. Use of pooled urine samples and automated DNA isolation to achieve improved sensitivity and cost-effectiveness of large-scale testing for Chlamydia trachomatis in pregnant women. J Clin Microbiol. 2005;43(9):4684–4690.10.1128/JCM.43.9.4684-4690.2005
   PubMed Web of Science ®Google Scholar
• Rours GI, Duijts L, Moll HA, et al. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. Eur J Epidemiol. 2011;26(6):493–502.10.1007/s10654-011-9586-1
   PubMed Web of Science ®Google Scholar
• Rours GI, de Krijger RR, Ott A, et al. Chlamydia trachomatis and placental inflammation in early preterm delivery. Eur J Epidemiol. 2011;26(5):421–428.10.1007/s10654-011-9569-2
   PubMed Web of Science ®Google Scholar
• Jaddoe VW, van Duijn CM, van der Heijden AJ, et al. The generation R study: design and cohort update until the age of 4 years. Eur J Epidemiol. 2008;23(12):801–811.10.1007/s10654-008-9309-4
   PubMed Web of Science ®Google Scholar
• The Netherlands Perinatal Registry. Perinatal care in the Netherlands 2008. Utrecht: Stichting Perinatale Registratie Nederland; 2011.
   Google Scholar
• de Vries R, van Bergen JE, de Jong-van den Berg, et al. Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data. Value Health. 2006;9(1):1–11.10.1111/j.1524-4733.2006.00075.x
   PubMed Web of Science ®Google Scholar
• Postma MJ, Welte R, van den Hoek JA, et al. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia trachomatis. Value Health. 2001;4(3):266–275.10.1046/j.1524-4733.2001.43009.x
   PubMedGoogle Scholar
• Scott LaMontagne D, Baster K, Emmett L, Nichols T, Randall S, McLean L, et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia recall study advisory group. Sex Transm Infect. [Multicenter Study Research Support, Non-U.S. Gov’t]. 2007;83(4):292–303.10.1136/sti.2006.022053
   PubMed Web of Science ®Google Scholar
• Briggs AH. Handling uncertainty in economic evaluation and presenting the results. In: Drummond M, McGuire A, editors. Economic evaluation in health care. Merging theory and practice. New York: Oxford University Press; 2001;172–214.
   Google Scholar
• Riteco JA, de Heij LJM, Luijn JCF, Wolff IR. Amstelveen: College voor Zorgverzekeringen. Guidelines for pharmacoeconomic research (in Dutch: Richtlijnen Voor Farmaco-economisch Onderzoek); 1999.
   Google Scholar
• de Vries R, van Bergen JE, de Jong-van den Berg LT, Postma MJ. Cost-utility of repeated screening for Chlamydia trachomatis. Value Health. 2008;11(2):272–274.10.1111/j.1524-4733.2007.00225.x
   PubMed Web of Science ®Google Scholar
• Coyne KS, Payne C, Bhattacharyya SK, Revicki DA, Thompson C, Corey R, et al. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health. 2004;7(4):455–463.10.1111/j.1524-4733.2004.74008.x
   PubMed Web of Science ®Google Scholar
• van Valkengoed IG, Morre SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes–implications for cost-effectiveness analyses. Int J Epidemiol. 2004;33(2):416–425.10.1093/ije/dyh029
   PubMed Web of Science ®Google Scholar
• Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. [Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. 2010;340:c164210.1136/bmj.c1642
   PubMed Web of Science ®Google Scholar
• Kekki M, Kurki T, Kotomaki T, Sintonen H, Paavonen J. Cost-effectiveness of screening and treatment for bacterial vaginosis in early pregnancy among women at low risk for preterm birth. Acta Obstet Gynecol Scand. [Research Support, Non-U.S. Gov’t]. 2004;83(1):27-36.10.1111/aog.2004.83.issue-1
   PubMed Web of Science ®Google Scholar
• Weström L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol. 1975;121(5):707–713.10.1016/0002-9378(75)90477-9
   PubMed Web of Science ®Google Scholar
• Rosenman MB, Mahon BE, Downs SM, Kleiman MB. Oral erythromycin prophylaxis vs watchful waiting in caring for newborns exposed to Chlamydia trachomatis. Arch Pediatr Adolesc Med. 2003;157(6):565–571.10.1001/archpedi.157.6.565
   PubMedGoogle Scholar
• Gillespie P, O’Neill C, Adams E, Turner K, O’Donovan D, Brugha R, et al. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland. Sex Transm Infect. 2012;88(3):222–228.10.1136/sextrans-2011-050067
   PubMed Web of Science ®Google Scholar
• Weström L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility. A cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992;19(4):185–192.10.1097/00007435-199207000-00001
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2015 Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2015;64(No. RR-3):1–140.
   Web of Science ®Google Scholar
• U.S. Preventive Services Task Force. Screening for Chlamydial infection: U.S. preventive services task force recommendation statement. Ann Intern Med. 2007;147(2):128–134.
   PubMed Web of Science ®Google Scholar
• Bernloehr A, Smith P, Vydelingum V. Antenatal care in the European Union: a survey on guidelines in all 25 member states of the community. Eur J Obstet Gynecol Reprod Biol. 2005;122(1):22–32.10.1016/j.ejogrb.2005.04.004
   PubMed Web of Science ®Google Scholar
• van Bergen J, Gotz HM, Richardus JH, Hoebe CJ, Broer J, Coenen AJ. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect. 2005;81(1):17–23.10.1136/sti.2004.010173
   PubMed Web of Science ®Google Scholar
• Price MJ, Ades AE, Soldan K, Welton NJ, Macleod J, Simms I, et al. The natural history of Chlamydia trachomatis infetion in women: a multi parameter evidence synthesis. Health Technol Assess. 2016;20:1–250.10.3310/hta20220
   PubMed Web of Science ®Google Scholar
• Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis. 1997;24(3):131–141.10.1097/00007435-199703000-00003
   PubMed Web of Science ®Google Scholar
• Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: a cost-effectiveness analysis of three strategies. Ann Intern Med. 1998;128(4):277–284.10.7326/0003-4819-128-4-199802150-00005
   PubMed Web of Science ®Google Scholar
• Roberts TE, Robinson S, Barton PM, et al. Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project. BMJ. 2007;335(7614):291.10.1136/bmj.39262.683345.AE
   PubMed Web of Science ®Google Scholar
• Adams EJ, Turner KM, Edmunds WJ. The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect. 2007;83(4):267–275.10.1136/sti.2006.024364
   PubMed Web of Science ®Google Scholar
• Ramos-Zepeda R, Perez-Medina R, Barba-Barajas M, Palma-Ramirez T, Flores-Garcia A, Garibaldi -Becerra V, et al. Chlamydia trachomatis infection in pregnant women with premature membrane rupture or premature delivery threat. Rev Biomed. 2001;12:158–165.
   Google Scholar
• Claman P, Toye B, Peeling RW, Jessamine P, Belclher J Serologic evidence of Chlamydia trachomatis infection and risk of preterm birth. Can Med Assoc J. 1995;153:259–262.
   Web of Science ®Google Scholar
• Gencay MI, Koskiniemi M, Saikku P, Puolakkainen M, Raivio K, Koskela P, et al. Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infect Dis. 1995;21:424–426.10.1093/clinids/21.2.424
   PubMed Web of Science ®Google Scholar
• Kataoka S, Yamada T, Chou K, Nishida R, Morikawa M, Minami M, et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol. 2006;44(1):51–55.10.1128/JCM.44.1.51-55.2006
   PubMed Web of Science ®Google Scholar
• Silveira MF, Ghanem KG, Erbelding EJ, Burke AE, Johnson HL, Singh RH. Chlamydia trachomatis infection during pregnancy and the risk of preterm birth: a case-control study. Int J STD AIDS. 2009;20(7):465–469.10.1258/ijsa.2008.008388
   PubMed Web of Science ®Google Scholar
• Donders GG, Moerman P, De Wet GH, Hooft P, Goubau P. The asscociation between Chlamydia cervicitis, chorioamnionitis, and neonatal complications. Arch Gynecol Obstet. 1991;249:79–85.10.1007/BF02390366
   PubMed Web of Science ®Google Scholar
• Kretzschmar M, Welte R, van den Hoek A, Postma MJ. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol. 2001;153(1):90–101.10.1093/aje/153.1.90
   PubMed Web of Science ®Google Scholar
• Welte R, Postma M, Leidl R, Kretzschmar M. Costs and effects of chlamydial screening: dynamic versus static modeling. Sex Transm Dis. 2005;32(8):474–483.10.1097/01.olq.0000161181.48687.cf
   PubMed Web of Science ®Google Scholar
• Quinn TC, Gaydos C, Shepherd M, Bobo L, Hook EW. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. J Am Med Assoc. 1996;276(21):1737–1742.10.1001/jama.1996.03540210045032
   PubMed Web of Science ®Google Scholar
• Hammerschlag MR, Cummings C, Roblin PM, Williams TH, Delke I Efficacy of neonatal ocular prophylaxis for the prevention of chlamydial and gonococcal conjunctivitis. N Engl J Med. 1989;320(12):769–772.10.1056/NEJM198903233201204
   PubMed Web of Science ®Google Scholar
• Ong JJ, Chen M, Hocking J, Fairley CK, Carter R, Bulfone L, et al. Chlamydia screening for pregnant women aged 16–25 years attending an antenatal service: a cost-effectiveness study. Br J Obstet Gynaecol 2015: DOI:10.1111/1471-0528.13567.
   Google Scholar
• Medline A, Joseph DD, Klausner JD. Lost opportunity to save newborn lives: variable national antenatal screening policies for Neisseria gonorrhoeae and Chlamydia trachomatis. Int J STD AIDS 2016 Jul 16. pii: 0956462416660483. Epub ahead of print.
   PubMed Web of Science ®Google Scholar